Tesamorelin 5mg | 10-Vial Kit | GHRH Analog | Egrifta
About this compound
QSC Tesamorelin (GHRH(1-44) analog — FDA-approved Egrifta) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Certificate of Analysis
Lab tested by JanoshikIndependent third-party HPLC / mass-spec analysis for Tesamorelin 5mg | 10-Vial Kit | GHRH Analog | Egrifta. Each report carries a unique key you can verify directly with the lab.
Tesamorelin 5mg | 10-Vial Kit | GHRH Analog | Egrifta
QSC Tesamorelin (GHRH(1-44) analog — FDA-approved Egrifta) — ≥99% HPLC purity, MS confirmed, Janoshik COA.
5mg ·single research unit
Preorder
This size is not listed in the current warehouse stock sheet. Order now and dispatch origin will be confirmed before fulfilment.
Crypto checkout - discreet, tracked shipping
Research Use Only - not for human or veterinary consumption. Handling restricted to qualified researchers.
- Form
- Lyophilized powder
- Stock status
- Preorder
- Shipping
- Confirmed before fulfilment
- Payment
- USDC · USDT
Related compounds
Retatrutide 10mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 10mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 30mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 30mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) — ≥99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 30mg | 10-Vial Kit | 300mg Total | GLP-1 Receptor Agonist
Semaglutide 30mg | 10-Vial Kit | 300mg Total | GLP-1 Receptor Agonist
Semaglutide 30mg — high-dose GLP-1R agonist research vial.
Adipotide 2mg | 10-Vial Kit | 20mg Total | Proapoptotic Adipose Peptide
Adipotide 2mg | 10-Vial Kit | 20mg Total | Proapoptotic Adipose Peptide
Adipotide 2mg | 10-Vial Kit — Proapoptotic peptidomimetic — selectively induces apoptosis in prohibitin-expressing white adipose vasculature, causing…